BioSig Selects Plexus Corp. as its Manufacturing Partner
September 28, 2021 09:15 ET
|
BioSig Technologies, Inc.
Westport, CT, Sept. 28, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors
September 21, 2021 10:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Sept. 21, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Increases Installation Footprint Adding St. Elizabeth’s Medical Center to Roster of Premium Medical Institutions Utilizing the PURE EP System
September 13, 2021 08:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Sept. 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Confirmed as a Participant of The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Virtual Symposium
August 31, 2021 10:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Aug. 31, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig’s Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm Symposium
August 19, 2021 11:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Aug. 19, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig To Host Presentations from Physician Users of its Signal Processing System for Arrhythmia Care during the annual Heart Rhythm 2021 convention
July 20, 2021 14:00 ET
|
BioSig Technologies, Inc.
Westport, CT, July 20, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig Latest Installation Broadens Clinical Footprint for its Signal Processing Technology for Electrophysiology
July 13, 2021 14:30 ET
|
BioSig Technologies, Inc.
Westport, CT, July 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig to Host Conference Call to Unblind Clinical Data Collected with its Signal Processing Technology for Arrhythmia Care
July 12, 2021 10:30 ET
|
BioSig Technologies, Inc.
Westport, CT, July 12, 2021 (GLOBE NEWSWIRE) -- Company to present results from PURE EP 2.0 Study - a multi-center, blinded, and randomized clinical trialLeading physicians evaluated signal data...
BioSig Announces Closing of Public Offering of Common Stock
July 07, 2021 16:10 ET
|
BioSig Technologies, Inc.
Westport, CT, July 07, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig Enters the New York Market with Its Signal Processing Technology for Electrophysiology
July 07, 2021 09:36 ET
|
BioSig Technologies, Inc.
Westport, CT, July 07, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...